|
||
|
||
Harnessing ferroptosis for cancer therapy: Mechanisms and therapeutic strategies (Review)Nabil Mouawad, Nour El Jaafari, Mirvat El Sibai, Ralph J. Abi-Habib View Abstract ❯ |
|
||
Oxaliplatin resistance in pancreatic ductal adenocarcinoma is non‑significantly mediated by diminished drug uptake but is highly linked to a poor apoptotic response to the cytotoxic threatHellen Röttgen, Lana Theurer, Teresa Peccerella, Ketaki Sandu, Johanna Weiss, Jürgen Burhenne, John P. Neoptolemos, Beate Köberle, Dirk Theile View Abstract ❯ |
|||
S100B drives glioblastoma invasion and migration through TGF‑β2‑mediated epithelial‑mesenchymal transitionXuemei Liao, Yuan Xu, Honghong Zhou, Qin Yi, Shifang Dong, Bin Tan View Abstract ❯ |
|||
Role of the SOX family in non‑small cell lung cancer: Molecular mechanisms and therapeutic implications (Review)Kaiwei Wang, Yaoqi Li, Zhening Guo, Lin Song, Xiaoliang Ding, Linsheng Liu, Tao Hu, Yicong Bian, Chenrong Huang, Liyan Miao View Abstract ❯ |
|||
Role of histone deacetylases in blood cancer: Exploring peptide‑based inhibitors as therapeutic strategies for leukemia treatment (Review)Yaneenart Suwanwong, Phornthip Ploensil View Abstract ❯ |
|||
The multidimensional regulatory network of the PD‑1/PD‑L1 axis in the esophageal squamous cell carcinoma microenvironment: Implications for novel combination therapies and precision immunotherapy (Review)Haoyue Lai, Lu Qi, Zhixuan Lin, Zhongwen Li View Abstract ❯ |
|||
From modification to malignancy: Bridging acetylation mechanisms and therapeutic innovations in melanoma (Review)Jingwen Wu, Xuxia Cai, Zimo Zhu, Xiahong Li, Kaoyuan Zhang, Chenchen Wu, Bo Yu, Cong Huang View Abstract ❯ |
|||
C‑terminal HSP90 inhibitor NCT‑58 impairs the cancer stem‑like phenotype and enhances chemotherapy efficacy in TNBCEunsun Jung, Yoon-Jae Kim, Kyoungmin Lee, Seojin Jang, Soeun Park, Eunhye Oh, Minsu Park, Seongjae Kim, Dongmi Ko, Yong Koo Kang, Kee Dal Nam, Lee Farrand, Cong-Truong Nguyen, Minh Thanh La, Jihyae Ann, Jeewoo Lee, Ji Young Kim, Jae Hong Seo View Abstract ❯ |
|||
Immune system, inflammatory response, and regulated cell death in breast cancer research (Review)Guangyao Li, Binghui Jin, Jialin Zhou, Shifeng Fang, Zhe Fan View Abstract ❯ |
|||
Characterization of the anticancer effect of mebendazole and its interaction with standard cytotoxic drugs in patient tumor cells <em>ex vivo</em> and in an <em>in vivo</em> mouse modelSharmineh Mansoori, Kristin Blom, Claes Andersson, Mårten Fryknäs, Rolf Larsson, Peter Nygren View Abstract ❯ |
|||
CD44 knockdown and TGF‑β inhibition modulate cell proliferation and invasion in claudin‑low breast cancer cellsRyoichi Matsunuma, Kazuo Kinoshita, Sae Imada, Shoko Sato, Ryosuke Hayami, Michiko Tsuneizumi View Abstract ❯ |
|||
LRRC59 inhibits perk pathway‑induced apoptosis and promotes cell proliferation, migration and invasion in colorectal cancer cellsXingdong Hou, Yuting Wang, Yuzhuo Chen, Peiyan Zhong, Guangzhi Wang, Baicheng Li, Bowei Lu, Hanyu Jiang, Shili Ning View Abstract ❯ |
|||
Comparative analysis of the efficacy and safety of antibody‑drug conjugates, radionuclide‑drug conjugates and their combination targeting claudin 18.2 in gastric cancer treatmentHuan Du, Xiao-Fei Hao, Bin-Wei Lin, Yu Zhang, Luo Rui, Jing Wang, Ming-Ming Tang, De-Cai Wang, Yi-Han Zhu, Jie Li, Tang-Zhi Dai, Yuchuan Yang, Xia Yang, Xiaobo Du View Abstract ❯ |
|||
Platelet‑circulating tumor cell crosstalk: A pivotal target in cancer diagnosis and therapy (Review)Lifang Zhang, Ye Yuan, Yan Deng, Lin Wang, Fenghua Chen View Abstract ❯ |
|||
|
06 - 08 November 2025, Acicastello, Catania, Sicily, Italy 30th International Congress on Molecular Medicine
|
|
Follow Us
|
|
|
|
|
Tel: +30 210 722 7809 Email: contact@spandidos-publications.com Website: www.spandidos-publications.com |
|
You have been sent this Table of Contents because you have opted to receive it. You can change or discontinue your e-mail alerts at any time by modifying your preferences on your Spandidos Publications account. |